Measure. Overnight in asia, you saw similar concerns as markets in both japan and korea came under pressure the nikkei down by 1. 3 , that is a 2 1 2 month low. Hang seng off by a third in europe, you can see similar concerns playing out there the cac is the biggest loser in the major averages declines of over 1. 25 and for stocks in italy and in spain if you want to check out what has been happening with currencies, the yen has been picking up some ground this morning. It is considered a traditional safe haven right now it looks like the dollaryen is at 109. 77, dollar up against the euro. Also seeing a big move in the swiss franc, seen as asafe haven trade. You check that out this morning, but weve also seen gold a little stronger and u. S. Treasuries picking up a bit as well and big news, disney says that it will pull its movies from netflix and launch its own streaming service, it will take several years to complete. Disney making that announcement as it released Quarterly Results
Silverstein had lifechanging news that set him on a new course. Reporter making smart bets on potential new medicine is how this Venture Capitalist built a 20year career. The stakes got a lot more personal. It wasnt until i saw a specialist when i noticed i had a slight tremor in my left leg that he was able to put it all together and say these are all symptoms of parkinsons disease. Diagnosed at age 49, he discovered he has a genetic form of parkinsons disease. There are no drugs approved to cure it or even slow its course. So jonathan and his wife natalie decided to take action. Given the fact that jonathan works in this space, we are uniquely positioned to potentially make a difference. Reporter they founded the Silverstein Foundation with 10 million of their own money. I sent out a thousand letters to Venture Capitalists, ceos, to hospitals, research labs. They came back with literally dozens of ideas. Reporter hes been traveling the world, meeting with researchers and donating blo
BETHESDA, Md., April 24, 2024 Gain Therapeutics, Inc. , a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule.
Gain Therapeutics (GANX) Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase 1 Clinical Trial of GT-02287 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.